» Articles » PMID: 24527184

Primary Reperfusion in Acute Right Ventricular Infarction: An Observational Study

Abstract

Aim: To investigate the impact of primary reperfusion therapy (RT) on early and late mortality in acute right ventricular infarction (RVI).

Methods: RVI patients (n = 679) were prospectively classified as without right ventricular failure (RVF) (class A, n = 425, 64%), with RVF (class B, n = 158, 24%) or with cardiogenic shock (CS) (class C, n = 96, 12%). Of the 679 patients, 148 (21.7%) were considered to be eligible for thrombolytic therapy (TT) and 351 (51.6%) for primary percutaneous coronary intervention (PPCI). TIMI 3-flow by TT was achieved for A, B and C RVI class in 65%, 64% and 0%, respectively and with PPCI in 93%, 91% and 87%, respectively.

Results: For class A without RT, the mortality rate was 7.9%, with TT was reduced to 4.4% (P < 0.01) and with PPCI to 3.2% (P < 0.01). Considering TT vs PPCI, PPCI was superior (P < 0.05). For class B without RT the mortality was 27%, decreased to 13% with TT (P < 0.01) and to 8.3% with PPCI (P < 0.01). In a TT and PPCI comparison, PPCI was superior (P < 0.01). For class C without RT the in-hospital mortality was 80%, with TT was 100% and with PPCI, the rate decreased to 44% (P < 0.01). At 8 years, the mortality rate without RT for class A was 32%, for class B was 48% and for class C was 85%. When PPCI was successful, the long-term mortality was lower than previously reported for the 3 RVI classes (A: 21%, B: 38%, C: 70%; P < 0.001).

Conclusion: PPCI is superior to TT and reduces short/long-term mortality for all RVI categories. RVI CS patients should be encouraged to undergo PPCI at a specialized center.

Citing Articles

Impact of right ventricular failure on the outcomes of acute inferior wall myocardial infarction.

Shrivastav R, Malik A, Hajra A, Goel A, Mandal A, Mukhopadhyay S Future Cardiol. 2024; 20(10):563-569.

PMID: 39041494 PMC: 11486014. DOI: 10.1080/14796678.2024.2378628.


Mechanism of heart failure after myocardial infarction.

Jiang H, Fang T, Cheng Z J Int Med Res. 2023; 51(10):3000605231202573.

PMID: 37818767 PMC: 10566288. DOI: 10.1177/03000605231202573.


Heart Failure After Right Ventricular Myocardial Infarction.

Nagele M, Flammer A Curr Heart Fail Rep. 2022; 19(6):375-385.

PMID: 36197627 PMC: 9653315. DOI: 10.1007/s11897-022-00577-8.


[Cardiogenic shock complicating myocardial infarction].

Werdan K, Ferrari M, Prondzinsky R, Russ M Herz. 2022; 47(1):85-100.

PMID: 35015088 DOI: 10.1007/s00059-021-05088-1.

References
1.
Pfisterer M . Right ventricular involvement in myocardial infarction and cardiogenic shock. Lancet. 2003; 362(9381):392-4. DOI: 10.1016/S0140-6736(03)14028-7. View

2.
Brodie B, Stuckey T, Hansen C, Bradshaw B, Downey W, Pulsipher M . Comparison of late survival in patients with cardiogenic shock due to right ventricular infarction versus left ventricular pump failure following primary percutaneous coronary intervention for ST-elevation acute myocardial infarction. Am J Cardiol. 2007; 99(4):431-5. DOI: 10.1016/j.amjcard.2006.09.091. View

3.
White H, Aylward P, Huang Z, Dalby A, Weaver W, Barvik S . Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial.... Circulation. 2005; 112(22):3391-9. DOI: 10.1161/CIRCULATIONAHA.105.551143. View

4.
Assali A, Teplitsky I, Ben-Dor I, Solodky A, Brosh D, Battler A . Prognostic importance of right ventricular infarction in an acute myocardial infarction cohort referred for contemporary percutaneous reperfusion therapy. Am Heart J. 2007; 153(2):231-7. DOI: 10.1016/j.ahj.2006.10.038. View

5.
Bueno H, Lopez-Palop R, Bermejo J, Lopez-Sendon J, Delcan J . In-hospital outcome of elderly patients with acute inferior myocardial infarction and right ventricular involvement. Circulation. 1997; 96(2):436-41. DOI: 10.1161/01.cir.96.2.436. View